US Biopharma Firm Amgen To Acquire Horizon Therapeutics For Nearly $28 Bn - Barron's

1 year ago 45

This transcript is for your personal, non-commercial usage only. To bid presentation-ready copies for organisation to your colleagues, clients oregon customers sojourn http://www.djreprints.com.

https://www.barrons.com/news/us-biopharma-firm-amgen-to-acquire-horizon-therapeutics-for-nearly-28-bn-01670848508

By AFP - Agence France Presse

December 12, 2022

Order Reprints
Print Article

Text size

The US biopharmaceutical steadfast Amgen said Monday it has reached statement to get Horizon Therapeutics, which specializes successful medicine for uncommon and auto-immune diseases, for $27.8 billion.

"The acquisition of Horizon is simply a compelling accidental for Amgen and 1 that is accordant with our strategy of delivering semipermanent maturation by providing innovative medicines that code the needs of patients who endure from superior diseases," Amgen CEO Robert Bradway said.

dho/dw/raz

The Barron's quality section was not progressive successful the instauration of the contented above. This communicative was produced by AFP. For much accusation spell to AFP.com.
© Agence France-Presse

Read Entire Article